Web Analytics


Our publications:
Our publications
Home Tags Posts tagged with "Yisheng Biopharma"

Tag: Yisheng Biopharma

Deal digest

China’s YishengBio eyes US capital markets via SPAC route

Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023

0

LATEST ON VANTAGE ASIA

MOST READ ON VANTAGE ASIA

Greatest gift to humankind or its biggest threat

Greatest gift to humankind or its biggest threat

By Mathew Chacko, Aadya Misra, Ada Shaharbanu and Ritika Acharya, Spice Route Legal
JILA announces In-house Legal Award winners

JILA announces inaugural In-house Legal Award winners

Trial Holdings' Japan IPO debut

Four firms act on Trial debut in this year’s largest Japan IPO

video

The right to company name under new Company Law

By Wang Kun and Ding Tianmiao, Blossom & Credit Law Firm
Spectra Law launches in Delhi

Asim Abbas aims to tap tech future with new firm Spectra Law

CBLJ-rising-star-2024-report

The A-List 2023-24: Rising Stars

100 young elite lawyers for China market

Correspondents

Compliance strategy

How consumer, retail companies can capture compliance and profits

By Quan Kaiming and Yuan Wei, AllBright Law Offices

Product-by-process claim lesson in appeal judgment

By Pravin Anand, Vaishali Mittal, and Siddhant Chamola, Anand and Anand
Compulsory Execution

Practical points for compulsory execution of listed company stocks

By Zhou Han, AnJie Broad
DSO criminal compliance obligations

New laws tighten DSOs’ criminal compliance obligations

By Ekin Zeng and Chen Yitao, AllBright Law Offices
Follow Law.asia
Law firms A-List lawyers Events Legal jobs • Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2024 Law.asia Limited. All rights reserved.
Imagined by DOOD Website Design

Join our mailing list for legal news and alerts

Sign up